Loss of Medicare coverage associated with kidney transplant outcomes

Kidney transplant recipients under 65 years of age qualify for Medicare coverage following transplantation, but coverage ends after three years. A new American Journal of Transplantation study found that failure of the transplanted kidney was 990 percent to 1630 percent higher for recipients who lost Medicare coverage before this three-year time point compared with recipients who lost Medicare on time. Those who lost coverage after this point had a lesser, but still marked, increased risk of kidney failure.

Recipients who lost coverage before or after the three-year time point also filled immunosuppressive medications at a significantly lower rate than those who lost coverage on time.

The study included 78,861 Medicare-covered kidney transplant recipients under 65 years of age.

The findings have significant policy implications, and they suggest that a close examination of the risks of Medicare loss, as well as the importance of medical coverage safety nets and access to immunosuppressive medications, must be examined.

Kidney transplantation has profound survival, quality of life, and cost benefits over dialysis for the treatment of end-stage kidney disease, and yet thousands of patients die every year while waiting for a kidney because it is such a scarce resource. Our findings strongly suggest that we need to more closely evaluate the health care system we have in place to make sure these transplanted patients don't end up back on dialysis simply because they can't afford the care they need."​

Dr. Allyson Hart, Lead Author, Hennepin Healthcare and the University of Minnesota, Minneapolis

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Semaglutide reduces urine albumin-to-creatinine ratio in overweight chronic kidney disease patients